Curaleaf Holdings (CURLF) EBT (QoQ) (2019 - 2026)
Curaleaf Holdings (CURLF) EBT (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Curaleaf Holdings | 2.50 Bn | 2.40 Bn | 169.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.11% |
| Mar 31, 2026 | -70.97% |
| Dec 31, 2025 | 31.11% |
| Sep 30, 2025 | -26.47% |
| Jun 30, 2025 | -17.20% |
| Mar 31, 2025 | 77.52% |
| Dec 31, 2024 | -519.25% |
| Sep 30, 2024 | 31.35% |
| Jun 30, 2024 | -49.40% |
| Mar 31, 2024 | 99.98% |
| Dec 31, 2023 | -168,521.02% |
| Sep 30, 2023 | -45.93% |
| Jun 30, 2023 | -682.62% |
| Mar 31, 2023 | 98.74% |
| Dec 31, 2022 | -3,015.21% |
| Sep 30, 2022 | -73.20% |
| Jun 30, 2022 | 49.17% |
| Mar 31, 2022 | 152.97% |
| Dec 31, 2021 | -1,278.40% |
| Sep 30, 2021 | -90.02% |